Facet Wealth Inc’s Bristol-Myers Squibb BMY Stock Holding History

Facet Wealth Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Buy	8,331 +1,913	+30%	+$110K	0.01%	220
2026 Q1	$389K	Buy	+6,418	New	+$374K	0.01%	208

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Facet Wealth Inc's BMY Position: Q2 2026 in Review

Facet Wealth Inc increased its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2026, buying an estimated $110K and bringing the position to 8,331 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #220.

Facet Wealth Inc first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Facet Wealth Inc held 8,331 shares of Bristol-Myers Squibb worth $480K as of Q2 2026.
Facet Wealth Inc bought 1,913 Bristol-Myers Squibb shares in Q2 2026, an estimated $110K.
Bristol-Myers Squibb made up 0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #220 holding.
Facet Wealth Inc first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.